0001209191-22-003405.txt : 20220114
0001209191-22-003405.hdr.sgml : 20220114
20220114210025
ACCESSION NUMBER: 0001209191-22-003405
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220112
FILED AS OF DATE: 20220114
DATE AS OF CHANGE: 20220114
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RAMSAY DAVID A
CENTRAL INDEX KEY: 0001283292
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36282
FILM NUMBER: 22533331
MAIL ADDRESS:
STREET 1: HALOZYME THERAPEUTICS, INC.
STREET 2: 11588 SORRENTO VALLEY ROAD, #17
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO
CENTRAL INDEX KEY: 0000920465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330361285
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 201 JONES ROAD, SUITE 400
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-715-3600
MAIL ADDRESS:
STREET 1: 201 JONES ROAD, SUITE 400
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-12
0
0000920465
LA JOLLA PHARMACEUTICAL CO
LJPC
0001283292
RAMSAY DAVID A
C/O LA JOLLA PHARMACEUTICAL COMPANY
201 JONES ROAD, SUITE 400
WALTHAM
MA
02451
1
0
0
0
Stock Option (Right to Buy)
4.81
2022-01-12
4
A
0
30000
0.00
A
2032-01-12
Common Stock
30000
30000
D
The stock options vest and become exercisable on January 12, 2023 subject to the Reporting Person's continued service to the Issuer through such date.
/s/ Michael Hearne, by power of attorney for David A. Ramsay
2022-01-14